Thursday, May 7, 2026

Tesla Falls Short: South Korea EV See Massive Growth in U.S. Market

In the first half of this year, sales of EVs in the U.S. auto market showed a slight decline compared to the previous year.

Neurophet AQUA AD Plus: Revolutionizing Alzheimer’s Diagnosis with AI at AD/PD 2026

Neurophet showcased its AI solutions for Alzheimer's at AD/PD 2026, aiming to foster collaborations in treatment development.

Fed Holds at 3.50%–3.75%: Markets Care Less About Rates and More About Who Replaces Powell in May 2026

The Fed held rates steady, focusing on the next chair's nomination. Rick Rieder's dovish stance may weaken the dollar, impacting markets.

Tag: EMA

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

A 90-Minute Cancer Infusion Could Soon Be Cut to 5 Minutes—and Celltrion Wants to Lead It

Celltrion has applied for EMA approval of Herzuma SC, a new breast cancer treatment, enhancing drug delivery and patient convenience.

CT-P55: How Celltrion’s New Biosimilar Approval Will Transform Clinical Trials in Europe

Celltrion receives EMA approval to reduce patient enrollment for CT-P55 trial, aiming to cut costs and duration of clinical development.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.